Aastrom to test Tissue Repair Cells in US spinal fusion trial
This article was originally published in Clinica
Executive Summary
Aastrom Biosciences is to test in a US FDA-approved clinical trial its Tissue Repair Cell (TRC) product as a means of forming new bone tissue in the spine.